Paid Clinical Trials in Washington

Showing 1 – 20 of 158 results

Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia

by CTG

in B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Other

Washington

Deadline:

03/01/2031

Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial

by CTG

in Hematopoietic and Lymphatic System Neoplasm

Other

Washington

Deadline:

07/31/2026

Optimizing Infection Prophylaxis Prior to Shoulder Surgery

by CTG

in Periprosthetic Joint Infection, Arthroplasty Shoulder

Other

Washington

Deadline:

12/31/2027

DePTH: De-emphasize PTH

by CTG

in Kidney Failure, Chronic, Chronic Kidney Disease-Mineral and Bone Disorder

Other

Washington

Deadline:

02/28/2027

Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury

by CTG

in Acute Spinal Cord Injury

Other

Washington

Deadline:

09/15/2027

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers’ Memorandum Study)

by CTG

in Type1 Diabetes Mellitus

Other

Washington

Deadline:

11/30/2028

Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer

by CTG

in Advanced Ovarian Cancer

Other

Washington

Deadline:

11/15/2027

Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial

by CTG

in Stage 0a Bladder Cancer AJCC v8, Stage I Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8, Localized Non-Muscle Invasive Bladder Urothelial Carcinoma

Other

Washington

Deadline:

05/31/2027

Bimatoprost as a Treatment for Graves’ Orbitopathy

by CTG

in Graves Ophthalmopathy

Other

Washington

Deadline:

07/01/2031

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Osteosarcoma, FIERCe Trial

by CTG

in Advanced Osteosarcoma

Other

Washington

Deadline:

01/31/2044

Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

by CTG

in Metabolic Health

Other

Washington

Deadline:

12/01/2026

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

by CTG

in Diabetes Mellitus Type 2

Other

Washington

Deadline:

02/28/2026

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

by CTG

in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Aggressive Non-Hodgkin Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, ALK-Positive Large B-Cell Lymphoma

Other

Washington

Deadline:

12/01/2031

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

by CTG

in Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Lymphoplasmacytic Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma

Other

Washington

Deadline:

01/06/2031

Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism

by CTG

in Autism

Other

Washington

Deadline:

10/31/2029

Impact of Cannabinoids on Menopause Symptoms

by CTG

in Menopause, Perimenopause

Other

Washington

Deadline:

01/12/2027

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

by CTG

in Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Follicular Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Lymphoplasmacytic Lymphoma

Other

Washington

Deadline:

03/01/2039

Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors

by CTG

in Colorectal Carcinoma, Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8

Other

Washington

Deadline:

07/01/2027

Modifiable Variables in Parkinsonism (MVP)

by CTG

in Progressive Supranuclear Palsy, Parkinson's Disease, Parkinsonism, MSA - Multiple System Atrophy, Shy-Drager Syndrome

Other

Washington

Deadline:

12/01/2030

Load more All clinical trials loaded.

Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia

Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial

Optimizing Infection Prophylaxis Prior to Shoulder Surgery

DePTH: De-emphasize PTH

Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers’ Memorandum Study)

Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer

Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial

Bimatoprost as a Treatment for Graves’ Orbitopathy

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Osteosarcoma, FIERCe Trial

Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

Testing a Mobile App to Improve Toothbrushing Skills and Habits in Teens With Autism

Impact of Cannabinoids on Menopause Symptoms

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors

Modifiable Variables in Parkinsonism (MVP)

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials in Washington

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps